ReviewEuropean journal of clinical pharmacology2019
Defining and classifying terminology for medication harm: a call for consensus.
Review in European journal of clinical pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 5 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 5 syntheses or guidelines pooled it.
- The association between age and medication-related hospital admission in adults: a systematic review and meta-analysis.International journal of clinical pharmacy · 2026Pooled it
- Effect of electronic drug-drug interaction alerts on patient and clinician outcomes: a systematic review.Journal of the American Medical Informatics Association : JAMIA · 2025Pooled it
- Reducing medication errors for adults in hospital settings.The Cochrane database of systematic reviews · 2021Pooled it
- Interventions to Reduce Pediatric Prescribing Errors in Professional Healthcare Settings: A Systematic Review of the Last Decade.Paediatric drugs · 2021Pooled it
- Mapping the prevalence and nature of drug related problems among hospitalised children in the United Kingdom: a systematic review.BMC pediatrics · 2019Pooled it
- Neuraxial Medication Administration Errors During Anaesthesia and Perioperative Management, Consequences, Contributing Human and Systemic Factors and Their Prevention: A Systematic Review.Pain and therapy · 2026Review
- Measuring Medication Related Harm: Proposed Guidance for Adverse Drug Event Adjudication to Harmonize Outcomes in Deprescribing Research.Journal of the American Geriatrics Society · 2026Article
- Machine learning risk prediction models for medication harm in hospitalised adult patients.Therapeutic advances in drug safety · 2026Article
- Clinical Factors Associated With Patterns of Medication Errors Among Pediatric Hospitalized Patients in Northwest Ethiopia: A Multicenter Prospective Observational Study.BioMed research international · 2026Observational
- Implications of pharmacy students' involvement in collecting the best possible medication histories in hospital settings: A scoping review.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists · 2025Article
- Criteria pharmacists use to refer patients to a post discharge pharmacist review clinic.Exploratory research in clinical and social pharmacy · 2025Article
- Proximity care pathways and digitalization: opportunities and concerns for medication safety management-Insights from the ProSafe study on community perspectives.Frontiers in public health · 2025Article
- Evaluating EHR-Integrated Digital Technologies for Medication-Related Outcomes and Health Equity in Hospitalised Adults: A Scoping Review.Journal of medical systems · 2024Article
- International Trends in Adverse Drug Event-Related Mortality from 2001 to 2019: An Analysis of the World Health Organization Mortality Database from 54 Countries.Drug safety · 2024Observational
- Adverse drug reactions in hospitals: population estimates for Portugal and the ICD-9-CM to ICD-10-CM crosswalk.BMC health services research · 2023Article
- Medication errors and associated factors among pediatric inpatients in public hospitals of gamo zone, southern Ethiopia.Heliyon · 2023Article
- Scoping Review of Studies Evaluating Frailty and Its Association with Medication Harm.Drugs & aging · 2022Article
- Drug-Related Hospital AdmissionsFrontiers in pharmacology · 2022Article
- Evaluation of older persons' medications: a critical incident technique study exploring healthcare professionals' experiences and actions.BMC health services research · 2021Article
- Population-Based Observational Study of Adverse Drug Event-Related Mortality in the Super-Aged Society of Japan.Drug safety · 2021Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe multiplicity in terms and definitions of medication-related harm has been a long-standing challenge for health researchers, clinicians, and regulatory bodies. The purpose of this narrative review was to report the diversity of terms; compare definitions, classifications, and models describing medication harm; and suggest which may be useful in both clinical practice and the research setting.
methodsA narrative review of key studies defining and/or classifying medication harm terminology was undertaken.
resultsThis review found that numerous terms are used to describe medication harm, and that there is a lack of consistency in current definitions, classifications, and applications. This lack of consistency applied across clinical jurisdictions and regulatory terminologies. A number of limitations in current definitions and classifications were identified. These included the exclusion of key types of medication harm events, ambiguous wording, and a lack of clarity and consensus on subclassifications. In general, there was some overlap in key models from the literature and these were presented to describe similarities and differences.
conclusionWithout uniformity quantifying, comparing, combining, or extrapolating medication harm data, such as a rate of harm in a specific population, is a challenge for those involved in medication safety and pharmacovigilance. There is a pressing need for further discussion and international consensus on this topic. Adoption of standard descriptors by practitioner groups, regulatory and policy organisations would foster quality improvement and patient safety.
Indexed as
Identifiers
30310967What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.